Crossmark

Feasibility study protocol for the evaluation of home blood pressure in patients receiving angiogenesis inhibitor therapy: a multicenter observational study

Crossref DOI link: https://doi.org/10.1038/s41440-025-02524-1

Published Online: 2026-01-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kitaoka, Kaori

Morimoto, Satoshi

Minegishi, Shintaro

Kato, Hiroshi

Kitahara, Yasuyuki

Shioyama, Wataru

Shiga, Taro

Tajiri, Kazuko

Shoji, Masaaki

Fukata, Mitsuhiro

Akazawa, Hiroshi

Mukai, Mikio

Yano, Yuichiro

Node, Koichi

Nishiyama, Akira
License Information

Text and Data Mining valid from 2026-01-07

Version of Record valid from 2026-01-07
More Information

Article History

Received: 13 August 2025

Revised: 30 November 2025

Accepted: 6 December 2025

First Online: 7 January 2026

Compliance with ethical standards

:

: M.M. has received speaking honoraria from Daiichi Sankyo, Ferring Pharmaceuticals and Janssen Pharmaceutical.

Document is current

Any future updates will be listed below